The International Pediatric Science conference takes off today in Riyadh - Middle East Business News and Information
Under the patronage of: The Ministry of Defense, K.S.A, and General Directorate for Health services, Ministry of Defense
In collaboration with Prince Sultan Military Medical City Continuing Professional Development Department, and participation of the Saudi Society of Pediatric Neurology
Under the patronage of: The Ministry of Defense, K.S.A, and General Directorate for Health services, Ministry of Defense, the International Pediatric Science conference takes off today in Riyadh, the leading event taking place from the 13th to the 15th of May, 2025 in Riyadh, in collaboration with Prince Sultan Military Medical City Continuing Professional Development Department, and participation of the Saudi Society of Pediatric Neurology.
The multidisciplinary conference brings together top local and regional doctors, researchers, and educators involved in pediatric and neonatal care, to discover innovation in pediatric healthcare, discuss emerging trends and inventions, exchange ideas, expand horizons, and learn from the leaders' new innovations the most critical issues in pediatrics including: nutrition, gastroenterology, infectious diseases, immunology, neurology, neonatal care and other Pediatric subspecialties.
In his opening remarks the conference chairman, Dr. Khalid Hundallah Consultant Pediatric Neurology, Chairman of Paediatric Department, Prince Sultan Military Medical City, Vice President, Saudi Pediatric Neurology Society, KSA. Said: 'We are honored to hold the International Pediatric Science conference under the patronage of Prince Sultan Military Medical City, one of the leading healthcare institutions in the Kingdom of Saudi Arabia. This pioneering regional event reflects our continued shared commitment to providing the best integrated healthcare for children by enhancing effective cooperation between various medical and nursing specialties and supporting bodies, ensuring that the child's health, psychological, and social needs are met in accordance with the highest international medical standards'.
'This prominent scientific event represents an integrated platform for exchanging experiences between a group of consultants, experts, and researchers specialized in pediatric medicine, to continue the pursuit of ensuring a better future for the next generation, and supporting scientific research, training, and continuous professional development for physicians, recognizing the importance of integration in providing safe, effective healthcare that relies on the latest scientific developments'. Added Dr. Khalid Hundallah.
The top paediatric experts will discuss a number of the most important topics in this field, including: Advances in Diagnosing and Treating Kawasaki Disease, Neurofibromatosis Type 1 and Plexiform Neurofibromas Current Landscape in KSA, emerging therapies and vaccines for RSV: A new era in Pediatric care, impact of pneumococcal vaccination on Pediatric health: Successes and future directions, Hemolytic Uremic Syndrome From diagnosis to management, the new update in outpatient Asthma management, Recurrent Pulmonary Infections: Appropriate diagnostic considerations. And more.
The conference Chairman is Dr. Khalid Hundallah Consultant Pediatric Neurology, Chairman of Paediatric Department, Prince Sultan Military Medical City, Vice President, Saudi Pediatric Neurology Society, KSA . And Chair of the of organizing committee is Dr. Khaled Baqais Pediatric Pulmonary Medicine Consultant, Head of Pulmonary Medicine Division, Prince Sultan Military Medical City, KSA . The organizing Committee includes Dr. Fahad Al-Abbas Pediatric Hematology & Oncology Consultant, Head of Pediatric Hematology Division, Prince Sultan Military Medical City, KSA , Dr. Abdulrahman Asiri Head of Pediatric Rheumatology Division, Executive Director of Academic Affairs, Prince Sultan Military Medical City, KSA , Dr. Faisal Al-Haffaf Pediatric Gastroenterology Consultant, Prince Sultan Military Medical City, KSA , Pediatric Hematology & Oncology Consultant, Head of Pediatric Hematology Division, Prince Sultan Military Medical City, KSA, Dr. Faten Al-Mijmaj Pediatric Endocrinology consultant, Head of Pediatric Endocrinology & Diabetes division, Prince Sultan Military Medical City, KSA , Dr. Majed Aloufi Pediatric Nephrology Consultant, Director of Pediatric Nephrology Department, Prince Sultan Military Medical City, KSA , Dr. Mansour AlQwaiee Pediatric Pulmonary Consultant, Prince Sultan Military Medical City, KSA, Ms. Reema Al-Zahrani Health Management Specialist, Prince Sultan Military Medical City, KSA .
And scientific committee includes : Prof. Fahad Bashiri Professor, Consultant Pediatric Neurologist and Epiliptologist, Department of Pediatrics, College of Medicine, King Saud University, President, Saudi Pediatric Neurology Society, KSA , Dr. Abdulrahman Al-Odayani Pediatric Infectious Disease Consultant, Director of Infection Control Center of Excellence, Prince Sultan Military Medical City, Associated Professor, Alfaisal University, KSA , Dr. Hassan Al-Ahmari Consultant General Pediatric Medicine, Head of General Pediatric Division, Prince Sultan Military Medical City, KSA , Dr. Malak Al-Samnan Consultant Neonatologist, Head of Neonatal Intensive Care Unit, Prince Sultan Military Medical City, KSA , Dr. May Al-Barrak Consultant, Pediatrics Infectious Diseases, Head of Pediatrics Infectious Diseasees Division and Patient Safety Division, Prince Sultan Military Medical City, KSA , Dr. Mohammed Al-Shahrani Consultant Pediatric Hematology Oncology &BMT, Head unit of pediatric Bone Marrow transplant, Prince Sultan Military Medical City, KSA , Prof. Sarar Mohamed Professor and consultant of Pediatric Genetic and Metabolic medicine Head of Pediatric Metabolic and Genetic Medicine Division, Prince Sultan Military Medical City, KSA , Dr. Yasser Al-Saheel Consultant Pediatric Intensivist, Prince Sultan Military Medical City, KSA.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
21-05-2025
- Mid East Info
Dubai Judicial Institute (DJI) organised an insightful workshop titled ‘Management of Partnerships and Their Impact on Community Sustainability,' in alignment with the objectives of the ‘Year of Community' and its theme ‘Hand in Hand.' The workshop aimed to promote a culture of institutional collaboration and shared responsibility across various sectors, while enhancing the effectiveness of partnerships as key drivers of sustainable development. This initiative reflects the UAE leadership's enduring vision for inclusive and resilient community advancement through strategic government collaboration. The workshop mainly focused on partnership management within government entities to reinforce the understanding of the legal and regulatory frameworks that govern public and community partnerships. It also sought to boost institutional capabilities in managing these partnerships, encourage strategic thinking for community sustainability, promote a culture of integration, and offer practical solutions to potential challenges. The program explored three main themes, including the legislative framework for government and community partnerships, governance of partnerships, and its contribution to promoting transparency and accountability, and analysing the community impact of partnerships. Her Excellency Judge Dr Ebtessam Ali Al Bedwawi, Director General of the Dubai Judicial Institute, stated: 'The workshop was organised as part of Dubai's strategic vision to reinforce cross-sector collaboration and lay foundations for effective community partnerships that advance sustainable development and public welfare. Through our dedicated training programs and workshops, we aim to raise legal awareness at both community and institutional levels, while cultivating a culture of shared responsibility. These continuous initiatives support the objectives of the ‘Year of the Community' and offer an interactive platform for participants to exchange ideas and experiences, inspiring conversations around innovative initiatives that reinforce institutional and community collaboration and convert regulatory frameworks into tools for empowering community development.' This workshop is aligned with DJI's relentless efforts to instil a culture of institutional cooperation, underscoring the substantial role of strategic partnerships in strengthening social cohesion and highlighting the significance of public-community collaboration as a key enabler of sustainable development.
The Pfizer Middle East, Russia and Africa (MERA) Maternal Immunization Summit: Born Ready brought together more than 80 medical experts, physicians, and healthcare professionals together in Cairo, Egypt to share insights on the latest efforts to prevent RSV in newborns The summit highlighted the critical role of maternal vaccinations in the successful prevention of RSV and shed light on global best practices for such vaccination programs. Dubai, UAE –May 2025: More than 80 international and regional healthcare experts have convened at the Pfizer MERA Maternal Immunization Summit: Born Ready to discuss issues pertaining to maternal immunization. The summit, entitled 'RISE: Respiratory Immunization Summit for Excellence' and, held from 16-17 May 2025 in Cairo, Egypt, focused on the growing burden of neonatal respiratory syncytial virus (RSV) and the role of maternal vaccination in its successful prevention. The summit aimed to increase awareness of the virus and its impact, in addition to the importance of maternal immunization in preventing RSV and protecting newborns. Experts addressed the challenges and barriers to the adoption of maternal immunization, shared best practices, and explored how healthcare providers can more effectively implement maternal immunization programs in the region. Professor Irene Cetin, Professor of Obstetrics and Gynecology, University of Milan and Head of Obstetrics, Mangiagalli Policlinico Hospital Fondazione IRCCS Cà Granda, Milan, Italy, said: 'Maternal immunization leverages the natural pregnancy process whereby antibodies – disease-fighting molecules – pass naturally from mother to baby through the placenta, starting in the second trimester and peaking during the third. Maternal antibodies help protect infants at birth and during the first few months of life, before they are eligible to receive vaccinations themselves.' The administration of a vaccine to an expectant mother activates the maternal immune system, triggering the production of immunoglobin G (IgG) antibodies, which pass through the placenta from the parental bloodstream. Professor Mohamed Momtaz, Emeritus Professor of Obstetrics and Gynecology, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt, said: 'Because of the way the placenta pumps antibodies into the fetus during the second and third trimesters of pregnancy, fetal IgG concentration usually exceeds the concentration of antibodies in the maternal circulation in full-term infants, meaning the baby is better protected from infectious diseases than the mother. This highlights the tremendous potential of maternal immunization to help prevent transmission of communicable diseases and reduce the impact of infections such as RSV. Furthermore, events like this summit encourage evidence-based conversations between healthcare providers and expectant mothers, while also highlighting practical approaches to communication and appropriate data sharing.' According to the World Health Organization, RSV – a seasonal virus that leads to infections of the lungs and respiratory tract – is the most common cause of acute lower respiratory infections in children globally[i], responsible for an estimated 33 million such infections, more than three million hospitalizations and almost 60,000 deaths per year in children under 5 years of age[ii]. This trend is reflected regionally, where RSV infections are the leading cause of acute respiratory tract infections in young children, typically peaking during the winter months or the rainy season in humid countries. Professor Hossam Al Tatari, Director of General Pediatrics and Pediatric Infectious Diseases Services at The Heart Medical Center, Al Ain, UAE said: 'RSV infection is very common, affecting almost all children within two years from birth. In adults and older, healthy children, RSV typically produces mild symptoms that mimic the common cold, but in the newborn babies below 6 months, and those otherwise immunocompromised, such as babies born prematurely, the infection can prove life-threatening. It is imperative that we explore every possible avenue to mitigate the risks associated with RSV, and take every step to prevent transmission, especially to the most vulnerable amongst us.' Highlighting the benefits of maternal immunization to newborns and immunocompromised infants, Dr Hammam Haridy, Senior Director Regional Medical & Scientific Affairs at Pfizer MERA said: 'Infections such as RSV, while potentially dangerous, are preventable with vaccination. Despite the significant impact of RSV in the region and across the globe, comprehensive and consistent region-wide surveillance and burden data across the Middle East and North Africa region are currently limited. Forums such as the Maternal Immunization Summit are therefore crucial to drive buy-in of healthcare providers in order to increase awareness and tackle vaccine hesitancy. By providing a platform via which stakeholders can connect and share data and insights, we can drive the conversation around maternal vaccination, ensuring we make best use of available data in our interactions.' Both the World Health Organization and the Strategic Group of Experts on Immunization recommend countries adopt measures to prevent severe RSV in infants[iii], with decisions on whether to use maternal immunization or monoclonal antibodies dependent upon a number of factors. Emphasizing the need for collaboration between the medical community and vaccine developers to ensure maximum success in prevention, Merih Cetinkaya, Professor of Pediatrics, Health Sciences University and Head of Neonatology at Basaksehir Cam Sakura, City Hospital, Istanbul, Turkey, said: 'Communicable diseases such as RSV have considerable impact on neonatal health, affecting both our populations and our healthcare systems, and vaccinations remain a cornerstone in lessening this impact. As healthcare providers, we share responsibility with stakeholders across the healthcare landscape to understand such diseases, to leverage innovation and technology, and to ensure equitable access to life-saving vaccines, especially for the most vulnerable members of our communities.' During the event, Pfizer underscored its ongoing commitment to shaping the future of public health through the power of vaccines. Over the years, Pfizer's vaccines have played a vital role in preventing, controlling, and in some cases nearly eradicating infectious diseases, safeguarding millions of lives around the world and across the MERA region. As a leader in biopharmaceutical innovation, the company remains deeply invested in research and development, driving forward new solutions with the aim of enhancing patient outcomes and advancing global health. About Pfizer: Breakthroughs That Change Patients' Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at
Mid East Info
14-05-2025
- Mid East Info
The International Pediatric Science conference takes off today in Riyadh - Middle East Business News and Information
Under the patronage of: The Ministry of Defense, K.S.A, and General Directorate for Health services, Ministry of Defense In collaboration with Prince Sultan Military Medical City Continuing Professional Development Department, and participation of the Saudi Society of Pediatric Neurology Under the patronage of: The Ministry of Defense, K.S.A, and General Directorate for Health services, Ministry of Defense, the International Pediatric Science conference takes off today in Riyadh, the leading event taking place from the 13th to the 15th of May, 2025 in Riyadh, in collaboration with Prince Sultan Military Medical City Continuing Professional Development Department, and participation of the Saudi Society of Pediatric Neurology. The multidisciplinary conference brings together top local and regional doctors, researchers, and educators involved in pediatric and neonatal care, to discover innovation in pediatric healthcare, discuss emerging trends and inventions, exchange ideas, expand horizons, and learn from the leaders' new innovations the most critical issues in pediatrics including: nutrition, gastroenterology, infectious diseases, immunology, neurology, neonatal care and other Pediatric subspecialties. In his opening remarks the conference chairman, Dr. Khalid Hundallah Consultant Pediatric Neurology, Chairman of Paediatric Department, Prince Sultan Military Medical City, Vice President, Saudi Pediatric Neurology Society, KSA. Said: 'We are honored to hold the International Pediatric Science conference under the patronage of Prince Sultan Military Medical City, one of the leading healthcare institutions in the Kingdom of Saudi Arabia. This pioneering regional event reflects our continued shared commitment to providing the best integrated healthcare for children by enhancing effective cooperation between various medical and nursing specialties and supporting bodies, ensuring that the child's health, psychological, and social needs are met in accordance with the highest international medical standards'. 'This prominent scientific event represents an integrated platform for exchanging experiences between a group of consultants, experts, and researchers specialized in pediatric medicine, to continue the pursuit of ensuring a better future for the next generation, and supporting scientific research, training, and continuous professional development for physicians, recognizing the importance of integration in providing safe, effective healthcare that relies on the latest scientific developments'. Added Dr. Khalid Hundallah. The top paediatric experts will discuss a number of the most important topics in this field, including: Advances in Diagnosing and Treating Kawasaki Disease, Neurofibromatosis Type 1 and Plexiform Neurofibromas Current Landscape in KSA, emerging therapies and vaccines for RSV: A new era in Pediatric care, impact of pneumococcal vaccination on Pediatric health: Successes and future directions, Hemolytic Uremic Syndrome From diagnosis to management, the new update in outpatient Asthma management, Recurrent Pulmonary Infections: Appropriate diagnostic considerations. And more. The conference Chairman is Dr. Khalid Hundallah Consultant Pediatric Neurology, Chairman of Paediatric Department, Prince Sultan Military Medical City, Vice President, Saudi Pediatric Neurology Society, KSA . And Chair of the of organizing committee is Dr. Khaled Baqais Pediatric Pulmonary Medicine Consultant, Head of Pulmonary Medicine Division, Prince Sultan Military Medical City, KSA . The organizing Committee includes Dr. Fahad Al-Abbas Pediatric Hematology & Oncology Consultant, Head of Pediatric Hematology Division, Prince Sultan Military Medical City, KSA , Dr. Abdulrahman Asiri Head of Pediatric Rheumatology Division, Executive Director of Academic Affairs, Prince Sultan Military Medical City, KSA , Dr. Faisal Al-Haffaf Pediatric Gastroenterology Consultant, Prince Sultan Military Medical City, KSA , Pediatric Hematology & Oncology Consultant, Head of Pediatric Hematology Division, Prince Sultan Military Medical City, KSA, Dr. Faten Al-Mijmaj Pediatric Endocrinology consultant, Head of Pediatric Endocrinology & Diabetes division, Prince Sultan Military Medical City, KSA , Dr. Majed Aloufi Pediatric Nephrology Consultant, Director of Pediatric Nephrology Department, Prince Sultan Military Medical City, KSA , Dr. Mansour AlQwaiee Pediatric Pulmonary Consultant, Prince Sultan Military Medical City, KSA, Ms. Reema Al-Zahrani Health Management Specialist, Prince Sultan Military Medical City, KSA . And scientific committee includes : Prof. Fahad Bashiri Professor, Consultant Pediatric Neurologist and Epiliptologist, Department of Pediatrics, College of Medicine, King Saud University, President, Saudi Pediatric Neurology Society, KSA , Dr. Abdulrahman Al-Odayani Pediatric Infectious Disease Consultant, Director of Infection Control Center of Excellence, Prince Sultan Military Medical City, Associated Professor, Alfaisal University, KSA , Dr. Hassan Al-Ahmari Consultant General Pediatric Medicine, Head of General Pediatric Division, Prince Sultan Military Medical City, KSA , Dr. Malak Al-Samnan Consultant Neonatologist, Head of Neonatal Intensive Care Unit, Prince Sultan Military Medical City, KSA , Dr. May Al-Barrak Consultant, Pediatrics Infectious Diseases, Head of Pediatrics Infectious Diseasees Division and Patient Safety Division, Prince Sultan Military Medical City, KSA , Dr. Mohammed Al-Shahrani Consultant Pediatric Hematology Oncology &BMT, Head unit of pediatric Bone Marrow transplant, Prince Sultan Military Medical City, KSA , Prof. Sarar Mohamed Professor and consultant of Pediatric Genetic and Metabolic medicine Head of Pediatric Metabolic and Genetic Medicine Division, Prince Sultan Military Medical City, KSA , Dr. Yasser Al-Saheel Consultant Pediatric Intensivist, Prince Sultan Military Medical City, KSA.
See - Sada Elbalad
09-01-2025
- See - Sada Elbalad
4 Israeli Soldiers Killed in Gaza
The Israeli military announced Tuesday the deaths of four soldiers in northern Gaza, bringing the total fatalities among Israeli troops since the start of the ground operation on October 27, 2023, to 367. In an official statement, the army confirmed, "The names of the four soldiers who fell in combat on Tuesday in northern Gaza have been cleared for publication." Additionally, the statement reported a senior officer sustained critical injuries during the clashes. Israeli media revealed that rehabilitation departments in hospitals have treated approximately 12,000 wounded soldiers since the onset of the Gaza conflict. According to Israel Radio, about two-thirds of these cases, nearly 8,000 soldiers, involve physical injuries, while almost half of the wounded are dealing with psychological trauma. Meanwhile, the northern front has also seen a surge in casualties. The Yedioth Ahronoth newspaper reported 900 injuries over the past month due to the ongoing military campaign in Lebanon. It added that around 1,000 wounded soldiers are admitted to the Ministry of Defense's rehabilitation department each month. Lemor Luria, the head of the Rehabilitation Department in the Israeli Ministry of Defense, recently stated, "We need a budgetary solution to address this growing challenge." As the war in Gaza and the northern front continues, the rising number of casualties highlights the escalating toll on Israeli forces and resources.
